ArticleAmerican heart journal2020

Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.

D H Frank Gommans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.